Darya-Varia Laboratoria Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Darya-Varia Laboratoria Tbk. trades at Rp1,560 (market cap 1.75T, 1.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Darya-Varia Laboratoria Tbk. is far larger — about 10.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 1.8K). Which is the better fit depends on your goals.
| DVLA | OBAT | |
|---|---|---|
Market Cap | 1.75T | 167.37B |
Volume | 1.8K | 96.7K |
Lot | 18 | 967 |
Turnover | 2.81M | 23.82M |
Average Price | 1,560 | 246.34 |
Value | 2.81M | 23.82M |
Indicative Equilibrium Price | 1,560 | 248 |
Indicative Equilibrium Volume | 1 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Darya-Varia Laboratoria Tbk (the Company) was established, under notarial deed No. 5 dated February 5, 1976 as amended byu deed No. 148 dated April 30, 1976 made before notary public Abdul Latief, S.H. The Company is specialized in the production of soft gelatin-based capsule.
Read more on DVLA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →